B, B, H, & B Inc’s Amgen AMGN Stock Holding History

B, B, H, & B Inc’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50	Closed	-$11K	–	35
2020 Q4	$11K	Buy	+50	New	+$11.5K	0.01%	111

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

B, B, H, & B Inc's AMGN Position: Q1 2021 in Review

B, B, H, & B Inc sold out of Amgen (AMGN) in Q1 2021, closing a stake of 50 shares — an estimated $11K sold.

B, B, H, & B Inc first reported a position in AMGN in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

B, B, H, & B Inc reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
B, B, H, & B Inc sold 50 Amgen shares in Q1 2021, an estimated $11K.
B, B, H, & B Inc first reported a position in Amgen in Q4 2020 and held it in 1 quarter.
B, B, H, & B Inc's Amgen position peaked at $11K in Q4 2020.
2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on B, B, H, & B Inc's 13F filing for Q1 2021, filed 11 May 2021.